Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs:
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2019
|
Schlagworte: | |
Online-Zugang: | Volltext Volltext Volltext |
Beschreibung: | 1 Online-Ressource |
DOI: | 10.1186/s13075-019-2064-y |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046886208 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 200907s2019 gw |||| o||u| ||||||eng d | ||
024 | 7 | |a 10.1186/s13075-019-2064-y |2 doi | |
024 | 7 | |a urn:nbn:de:bvb:29-opus4-143391 |2 urn | |
035 | |a (OCoLC)1197715053 | ||
035 | |a (DE-599)BVBBV046886208 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-29 | ||
084 | |a 610 |2 sdnb | ||
084 | |a 616.7 |2 sdnb | ||
100 | 1 | |a Moel, Emma C. de |e Verfasser |4 aut | |
245 | 1 | 0 | |a Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |c Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude |
264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2019 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
650 | 0 | |a Rheumatology. | |
650 | 0 | |a Orthopedics. | |
653 | |a Rheumatology. | ||
653 | |a Orthopedics. | ||
700 | 1 | |a Rech, Jürgen |e Verfasser |4 aut | |
700 | 1 | |a Mahler, Michael |e Verfasser |4 aut | |
700 | 1 | |a Roth, Johannes |e Verfasser |4 aut | |
700 | 1 | |a Vogl, Thomas |e Verfasser |4 aut | |
700 | 1 | |a Schouffoer, Anne |e Verfasser |4 aut | |
700 | 1 | |a Goekoop, Robbert J. |e Verfasser |4 aut | |
700 | 1 | |a Huizinga, Tom W. J. |e Verfasser |4 aut | |
700 | 1 | |a Allaart, Cornelia F. |e Verfasser |4 aut | |
700 | 1 | |a Toes, René E. M. |e Verfasser |4 aut | |
700 | 1 | |a Schett, Georg |e Verfasser |4 aut | |
700 | 1 | |a Woude, Diane van der |e Verfasser |4 aut | |
787 | 0 | 8 | |i Sonderdruck aus |t Arthritis Research & Therapy |g Vol. 21 (2019) |o 10.1186/s13075-019-2064-y |
856 | 4 | 0 | |u https://doi.org/10.1186/s13075-019-2064-y |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-143391 |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://open.fau.de/handle/openfau/14339 |x Verlag |z kostenfrei |3 Volltext |
912 | |a ebook | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-032296118 |
Datensatz im Suchindex
_version_ | 1804181747556941824 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Moel, Emma C. de Rech, Jürgen Mahler, Michael Roth, Johannes Vogl, Thomas Schouffoer, Anne Goekoop, Robbert J. Huizinga, Tom W. J. Allaart, Cornelia F. Toes, René E. M. Schett, Georg Woude, Diane van der |
author_facet | Moel, Emma C. de Rech, Jürgen Mahler, Michael Roth, Johannes Vogl, Thomas Schouffoer, Anne Goekoop, Robbert J. Huizinga, Tom W. J. Allaart, Cornelia F. Toes, René E. M. Schett, Georg Woude, Diane van der |
author_role | aut aut aut aut aut aut aut aut aut aut aut aut |
author_sort | Moel, Emma C. de |
author_variant | e c d m ecd ecdm j r jr m m mm j r jr t v tv a s as r j g rj rjg t w j h twj twjh c f a cf cfa r e m t rem remt g s gs d v d w dvd dvdw |
building | Verbundindex |
bvnumber | BV046886208 |
collection | ebook |
ctrlnum | (OCoLC)1197715053 (DE-599)BVBBV046886208 |
discipline | Medizin |
discipline_str_mv | Medizin |
doi_str_mv | 10.1186/s13075-019-2064-y |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02280nmm a2200541zc 4500</leader><controlfield tag="001">BV046886208</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">200907s2019 gw |||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/s13075-019-2064-y</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-143391</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1197715053</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046886208</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">616.7</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Moel, Emma C. de</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs</subfield><subfield code="c">Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Rheumatology.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Orthopedics.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Rheumatology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Orthopedics.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rech, Jürgen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahler, Michael</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roth, Johannes</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vogl, Thomas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schouffoer, Anne</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goekoop, Robbert J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Huizinga, Tom W. J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allaart, Cornelia F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Toes, René E. M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schett, Georg</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Woude, Diane van der</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Arthritis Research & Therapy</subfield><subfield code="g">Vol. 21 (2019)</subfield><subfield code="o">10.1186/s13075-019-2064-y</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1186/s13075-019-2064-y</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-143391</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/14339</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032296118</subfield></datafield></record></collection> |
id | DE-604.BV046886208 |
illustrated | Not Illustrated |
index_date | 2024-07-03T15:19:38Z |
indexdate | 2024-07-10T08:56:34Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032296118 |
oclc_num | 1197715053 |
open_access_boolean | 1 |
owner | DE-29 |
owner_facet | DE-29 |
physical | 1 Online-Ressource |
psigel | ebook |
publishDate | 2019 |
publishDateSearch | 2019 |
publishDateSort | 2019 |
publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
record_format | marc |
spelling | Moel, Emma C. de Verfasser aut Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2019 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Rheumatology. Orthopedics. Rech, Jürgen Verfasser aut Mahler, Michael Verfasser aut Roth, Johannes Verfasser aut Vogl, Thomas Verfasser aut Schouffoer, Anne Verfasser aut Goekoop, Robbert J. Verfasser aut Huizinga, Tom W. J. Verfasser aut Allaart, Cornelia F. Verfasser aut Toes, René E. M. Verfasser aut Schett, Georg Verfasser aut Woude, Diane van der Verfasser aut Sonderdruck aus Arthritis Research & Therapy Vol. 21 (2019) 10.1186/s13075-019-2064-y https://doi.org/10.1186/s13075-019-2064-y Resolving-System kostenfrei Volltext https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-143391 Resolving-System kostenfrei Volltext https://open.fau.de/handle/openfau/14339 Verlag kostenfrei Volltext |
spellingShingle | Moel, Emma C. de Rech, Jürgen Mahler, Michael Roth, Johannes Vogl, Thomas Schouffoer, Anne Goekoop, Robbert J. Huizinga, Tom W. J. Allaart, Cornelia F. Toes, René E. M. Schett, Georg Woude, Diane van der Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs Rheumatology. Orthopedics. |
title | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |
title_auth | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |
title_exact_search | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |
title_exact_search_txtP | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |
title_full | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude |
title_fullStr | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude |
title_full_unstemmed | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs Emma C. de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl, Anne Schouffoer, Robbert J. Goekoop, Tom W. J. Huizinga, Cornelia F. Allaart, René E. M. Toes, Georg Schett, Diane van der Woude |
title_short | Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs |
title_sort | circulating calprotectin s100a8 a9 is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti rheumatic drugs |
topic | Rheumatology. Orthopedics. |
topic_facet | Rheumatology. Orthopedics. |
url | https://doi.org/10.1186/s13075-019-2064-y https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-143391 https://open.fau.de/handle/openfau/14339 |
work_keys_str_mv | AT moelemmacde circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT rechjurgen circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT mahlermichael circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT rothjohannes circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT voglthomas circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT schouffoeranne circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT goekooprobbertj circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT huizingatomwj circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT allaartcorneliaf circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT toesreneem circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT schettgeorg circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs AT woudedianevander circulatingcalprotectins100a8a9ishigherinrheumatoidarthritispatientsthatrelapsewithin12monthsoftaperingantirheumaticdrugs |